Show simple item record

dc.contributor.authorCruz-Garcia, L
dc.contributor.authorBadie, C
dc.contributor.authorAnbalagan, S
dc.contributor.authorMoquet, J
dc.contributor.authorGothard, L
dc.contributor.authorO'Brien, G
dc.contributor.authorSomaiah, N
dc.contributor.authorAinsbury, EA
dc.date.accessioned2021-06-30T11:49:20Z
dc.date.available2021-06-30T11:49:20Z
dc.date.issued2021-05-03
dc.identifier.citationRadiation oncology (London, England), 2021, 16 (1), pp. 83 - ?
dc.identifier.issn1748-717X
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4652
dc.identifier.eissn1748-717X
dc.identifier.doi10.1186/s13014-021-01807-4
dc.description.abstractBACKGROUND: This communication reports the identification of a new panel of transcriptional changes in inflammation-associated genes observed in response to ionising radiation received by radiotherapy patients. METHODS: Peripheral blood samples were taken with ethical approval and informed consent from a total of 20 patients undergoing external beam radiotherapy for breast, lung, gastrointestinal or genitourinary tumours. Nanostring nCounter analysis of transcriptional changes was carried out in samples prior and 24 h post-delivery of the 1st radiotherapy fraction, just prior to the 5th or 6th fraction, and just before the last fraction. RESULTS: Statistical analysis with BRB-ArrayTools, GLM MANOVA and nSolver, revealed a radiation responsive panel of genes which varied by patient group (type of cancer) and with time since exposure (as an analogue for dose received), which may be useful as a biomarker of radiation response. CONCLUSION: Further validation in a wider group of patients is ongoing, together with work towards a full understanding of patient specific responses in support of personalised approaches to radiation medicine.
dc.formatElectronic
dc.format.extent83 - ?
dc.languageeng
dc.language.isoeng
dc.publisherBMC
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleAn ionising radiation-induced specific transcriptional signature of inflammation-associated genes in whole blood from radiotherapy patients: a pilot study.
dc.typeJournal Article
dcterms.dateAccepted2021-04-13
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1186/s13014-021-01807-4
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2021-05-03
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfRadiation oncology (London, England)
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Breast Radiobiology
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Breast Radiobiology
pubs.publication-statusPublished
pubs.volume16
pubs.embargo.termsNot known
icr.researchteamTranslational Breast Radiobiology
icr.researchteamTranslational Breast Radiobiology
dc.contributor.icrauthorAnbalagan, Selvakumar
dc.contributor.icrauthorGothard, Lone
dc.contributor.icrauthorSomaiah, Navita


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0